Holen Sie sich die Stockscreener-App
3.54
4.73%
0.16
Handel nachbörslich:
3.52
-0.02
-0.56%
Schlusskurs vom Vortag:
$3.38
Offen:
$3.34
24-Stunden-Volumen:
476.06K
Relative Volume:
0.43
Marktkapitalisierung:
$262.89M
Einnahmen:
$6.96M
Nettoeinkommen (Verlust:
$-46.51M
KGV:
-20.63
EPS:
-0.1716
Netto-Cashflow:
$-37.99M
1W Leistung:
+4.73%
1M Leistung:
-9.00%
6M Leistung:
+50.64%
1J Leistung:
-76.37%
1-Tages-Spanne:
$3.20
$3.54
1-Wochen-Bereich:
$3.20
$3.54
52-Wochen-Spanne:
$1.60
$16.31
Perspective Therapeutics Inc Stock (CATX) Company Profile
Firmenname
Perspective Therapeutics Inc
Sektor
Branche
Telefon
509-375-1202
Adresse
350 Hills Street, Suite 106, Richland
Vergleichen Sie CATX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CATX
Perspective Therapeutics Inc
|
3.54 | 246.55M | 6.96M | -46.51M | -37.99M | -0.1716 |
|
ABT
Abbott Laboratories
|
132.81 | 228.80B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
107.29 | 158.04B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
394.34 | 149.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.85 | 119.71B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
80.96 | 48.01B | 5.69B | 1.41B | 577.90M | 6.95 |
Perspective Therapeutics Inc Stock (CATX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-03-07 | Eingeleitet | Scotiabank | Sector Outperform |
| 2024-11-25 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-24 | Eingeleitet | UBS | Buy |
| 2024-10-01 | Eingeleitet | Wedbush | Outperform |
| 2024-09-25 | Eingeleitet | Truist | Buy |
| 2024-07-25 | Eingeleitet | BofA Securities | Buy |
| 2024-05-09 | Eingeleitet | Cantor Fitzgerald | Overweight |
Alle ansehen
Perspective Therapeutics Inc Aktie (CATX) Neueste Nachrichten
Perspective Therapeutics shares fall 1.02% after-hours following appointment of Maya Martinez-Davis to the Board of Directors. - AInvest
How does Perspective Therapeutics Inc. score in quality rankingsWeekly Stock Summary & AI Enhanced Trading Signals - khodrobank.com
Published on: 2025-09-03 09:07:22 - Newser
What institutional flow reveals about Perspective Therapeutics Inc.July 2025 Selloffs & Low Drawdown Investment Strategies - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board - TipRanks
Analyzing drawdowns of Perspective Therapeutics Inc. with statistical tools2025 Year in Review & Real-Time Stock Entry Alerts - Newser
What indicators show strength in Perspective Therapeutics Inc.Chart Signals & Proven Capital Preservation Tips - Newser
Perspective Therapeutics Appoints Maya Martinez-Davis to Board, Boosting Oncology Expertise - AInvest
Perspective Therapeutics Appoints Maya Martinez-Davis to Board of Directors - MarketScreener
Published on: 2025-09-03 04:22:19 - Newser
Published on: 2025-09-03 04:21:25 - Newser
How to use a screener to detect Perspective Therapeutics Inc. breakoutsJuly 2025 Reactions & Verified Stock Trade Ideas - Newser
Custom strategy builders for tracking Perspective Therapeutics Inc.July 2025 Selloffs & Weekly High Return Stock Forecasts - Newser
Perspective Therapeutics Inc.’s volatility index tracking explainedJuly 2025 News Drivers & Risk Adjusted Swing Trade Ideas - Newser
Published on: 2025-09-03 01:26:42 - Newser
Building trade automation scripts for Perspective Therapeutics Inc.Weekly Risk Summary & Weekly Setup with High ROI Potential - Newser
ETF Watch: Does Perspective Therapeutics Inc. stock have upside surprise potentialJuly 2025 Technicals & Reliable Price Breakout Alerts - khodrobank.com
Using fundamentals and technicals on Perspective Therapeutics Inc.Quarterly Portfolio Review & Daily Momentum Trading Reports - Newser
Is Perspective Therapeutics Inc. stock entering bullish territoryIPO Watch & Fast Moving Market Watchlists - Newser
Is Perspective Therapeutics Inc. gaining market shareEarnings Risk Report & Daily Profit Focused Stock Screening - khodrobank.com
Perspective Therapeutics Updates on Radiopharmaceutical Advancements - TipRanks
Is a relief rally coming for Perspective Therapeutics Inc. holdersMarket Growth Report & Community Consensus Picks - Newser
Smart tools for monitoring Perspective Therapeutics Inc.’s price actionJuly 2025 Institutional & Real-Time Chart Pattern Alerts - Newser
Can Perspective Therapeutics Inc. deliver alphaCPI Data & Weekly High Return Forecasts - khodrobank.com
Update Recap: Is Perspective Therapeutics Inc. gaining market share2025 Fundamental Recap & Long-Term Investment Growth Plans - khodrobank.com
Is Perspective Therapeutics Inc. being accumulated by smart moneyJobs Report & Weekly Setup with High ROI Potential - khodrobank.com
Chart overlay techniques for tracking Perspective Therapeutics Inc.July 2025 PreEarnings & Low Risk High Reward Ideas - Newser
Does Perspective Therapeutics Inc. stock reflect fundamentalsWeekly Profit Summary & Daily Growth Stock Tips - khodrobank.com
Perspective Therapeutics Inc. Trading Near Value Zone — Recovery Ahead getLinesFromResByArray error: size == 0 - kangso.co.kr
Can volume confirm reversal in Perspective Therapeutics Inc.July 2025 EndofMonth & Real-Time Market Sentiment Alerts - Newser
Perspective Therapeutics Inc. Volume Confirms Breakout — Analysts Bullish getLinesFromResByArray error: size == 0 - kangso.co.kr
How institutional ownership impacts Perspective Therapeutics Inc. stockWeekly Investment Summary & Accurate Buy Signal Alerts - Newser
What technical models suggest about Perspective Therapeutics Inc.’s comebackGap Down & Daily Risk Controlled Trade Plans - Newser
Technical signs of recovery in Perspective Therapeutics Inc.Fed Meeting & Reliable Price Breakout Signals - Newser
Using data tools to time your Perspective Therapeutics Inc. exitBear Alert & Low Risk High Win Rate Stock Picks - Newser
Will Perspective Therapeutics Inc. bounce back from current support2025 Price Momentum & Weekly Setup with ROI Potential - Newser
Volume spikes in Perspective Therapeutics Inc. stock – what they meanSell Signal & Daily Growth Stock Investment Tips - Newser
Measuring Perspective Therapeutics Inc.’s beta against major indicesQuarterly Growth Report & Stock Timing and Entry Methods - Newser
Ranking Perspective Therapeutics Inc. among high performing stocks via toolsPortfolio Performance Report & High Accuracy Buy Signal Tips - Newser
Can Perspective Therapeutics Inc. hit a new high this monthJuly 2025 Recap & AI Enhanced Trading Alerts - Newser
Technical signs of recovery in Perspective Therapeutics Inc2025 Geopolitical Influence & Long Hold Capital Preservation Plans - Newser
Finanzdaten der Perspective Therapeutics Inc-Aktie (CATX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.38%
0.32%
Kapitalisierung:
|
Volumen (24h):